60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
Relative Value
The Relative Value of one SXTP stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.16 USD, 60 Degrees Pharmaceuticals Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SXTP Competitors Multiples
60 Degrees Pharmaceuticals Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
6
|
60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
|
4.4m USD | 3.2 | -0.5 | -0.1 | -0.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD | 15.7 | 49.5 | 33.3 | 35.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD | 6.1 | 21.5 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.8B CHF | 4.6 | 30.2 | 12.7 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD | 4.7 | 16.6 | 10.4 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.3B CHF | 5.3 | 21.3 | 13.1 | 16.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 5.2 | 32.1 | 15.3 | 22.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.6 | 10 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD | 2.6 | 17.9 | 7 | 8.9 |